000 | 01913 a2200553 4500 | ||
---|---|---|---|
005 | 20250517111533.0 | ||
264 | 0 | _c20170221 | |
008 | 201702s 0 0 eng d | ||
022 | _a1998-3646 | ||
024 | 7 |
_a10.4103/0255-0857.188320 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKumar, D | |
245 | 0 | 0 |
_aIdentification, antifungal resistance profile, in vitro biofilm formation and ultrastructural characteristics of Candida species isolated from diabetic foot patients in Northern India. _h[electronic resource] |
260 |
_bIndian journal of medical microbiology _c |
||
300 |
_a308-14 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAmphotericin B _xpharmacology |
650 | 0 | 4 |
_aAntifungal Agents _xpharmacology |
650 | 0 | 4 |
_aBiofilms _xgrowth & development |
650 | 0 | 4 |
_aCandida _xclassification |
650 | 0 | 4 |
_aDNA, Fungal _xchemistry |
650 | 0 | 4 |
_aDNA, Ribosomal _xchemistry |
650 | 0 | 4 |
_aDNA, Ribosomal Spacer _xchemistry |
650 | 0 | 4 |
_aDiabetic Foot _xmicrobiology |
650 | 0 | 4 | _aDrug Resistance, Fungal |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFluconazole _xpharmacology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIndia |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMicrobial Sensitivity Tests |
650 | 0 | 4 | _aMicrobiological Techniques |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aMolecular Diagnostic Techniques |
650 | 0 | 4 |
_aRNA, Ribosomal, 18S _xgenetics |
650 | 0 | 4 |
_aRNA, Ribosomal, 28S _xgenetics |
650 | 0 | 4 | _aSequence Analysis, DNA |
650 | 0 | 4 | _aSpecimen Handling |
650 | 0 | 4 |
_aVoriconazole _xpharmacology |
700 | 1 | _aBanerjee, T | |
700 | 1 | _aChakravarty, J | |
700 | 1 | _aSingh, S K | |
700 | 1 | _aDwivedi, A | |
700 | 1 | _aTilak, R | |
773 | 0 |
_tIndian journal of medical microbiology _gvol. 34 _gno. 3 _gp. 308-14 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.4103/0255-0857.188320 _zAvailable from publisher's website |
999 |
_c26319250 _d26319250 |